000 | 01199 a2200349 4500 | ||
---|---|---|---|
005 | 20250515025250.0 | ||
264 | 0 | _c20060606 | |
008 | 200606s 0 0 eng d | ||
022 | _a0017-5749 | ||
024 | 7 |
_a10.1136/gut.2006.091496 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCapra, F | |
245 | 0 | 0 |
_aIs the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy? _h[electronic resource] |
260 |
_bGut _cJun 2006 |
||
300 |
_a902 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aBlood Coagulation Disorders _xchemically induced |
650 | 0 | 4 | _aBlood Coagulation Tests |
650 | 0 | 4 |
_aFactor VIII _xantagonists & inhibitors |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
650 | 0 | 4 | _aRecombinant Proteins |
700 | 1 | _aNicolini, N | |
700 | 1 | _aFranchini, M | |
773 | 0 |
_tGut _gvol. 55 _gno. 6 _gp. 902 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2006.091496 _zAvailable from publisher's website |
999 |
_c16298750 _d16298750 |